top of page

Peptide Spotlight: Epithalon

Turn Back Your Chronological Age!

Primary Benefit:  Epithalon is commonly referred to as the “primary anti-aging peptide”. It is one of the very few synthesized compounds that has been shown to directly activate the telomerase enzyme in humans. Telomerase renews and elongates telomeres, the caps on the ends of chromosomes that protect DNA from damage and cancer-causing errors. By activating telomerase, Epithalon can reduce the shortening of telomeres, theoretically helping you “age backward.”


  • May be the ultimate anti-aging peptide

  • Proven to increase telomere length and decrease mortality

  • Stimulates healthy pineal gland synthesis of serotonin and melatonin

  • Slows down aging of the reproductive system

  • Increases conversion of T4 to T3 thyroid hormone

  • Improves glucose tolerance

  • Decreases insulin and triglyceride levels

  • Increase in longevity

  • Decrease in mortality and cancer.

  • Improves hypothalamic-pituitary dysfunction seen with disease and aging

  • Increases mean and maximal lifespan in animals

  • Immune support by improving natural killer cell and T-helper cell function.

  • After three years of epithalon and other bio-regulator peptide therapy, human studies showed a 22-year decrease in telomere age.

Dosage: Daily for 10-30 days in the morning.  Repeat twice a year for best anti-aging results.

Side Effects: No real side effects. May improve sleep. May cause temporary facial flushing. If so then use kidney supplements or an anti-histamine.

Cons: No visible results. Telomere testing is about $500 but changes take place over years, so testing for the average people isn’t worth the cost.  No need to use this peptide if you are under age 40.

Want to learn more? Bill Lawrence has lowered his telomere age from in the 70s to about 40! Now at a real age of 76, he and his wife are still ballroom dancing and very active. His human studies are just now getting published, and the results are amazing. Listen to his podcast with Nathalie Niddam here:


Recent Posts

See All


bottom of page